{"name": "Peter Lenardos", "children": [{"name": "capital expenditure program", "questions": ["I just had a question about your capital expenditure program. I was hoping you could comment on how much capital expenditures were incurred in 2012, and how much you plan on incurring in 2013. Thank you."]}, {"name": "recent regulation", "questions": ["I just have a question on the recent regulations that were enacted surrounding high frequency trading and the potential impact on your business from those new regulations. Thank you."]}, {"name": "business", "questions": ["I just have a question on the recent regulations that were enacted surrounding high frequency trading and the potential impact on your business from those new regulations. Thank you.", "Hi, good afternoon, it's Peter Lenardos from RBC in London. I had a question about Xetra. I understand it's a small part of the business, but the revenue yield looks to have declined dramatically during the quarter. And I was hoping you could comment on why that's the case and if competition had any impact on that. Thank you."]}, {"name": "regulation", "questions": ["I just have a question on the recent regulations that were enacted surrounding high frequency trading and the potential impact on your business from those new regulations. Thank you."]}, {"name": "recent", "questions": ["Hello. Good afternoon. I just was hoping you could comment on the recent MiFID II proposals, specifically with regards to non-discriminatory access to indices and the open access requirement, as well. Thank you.", "I just have a question on the recent regulations that were enacted surrounding high frequency trading and the potential impact on your business from those new regulations. Thank you.", "Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks."]}, {"name": "exceptional cost", "questions": ["You indicated that you took EUR78 million in exceptional costs in the first nine months for efficiency measures. I was wondering if you could quantify the amount of savings that EUR78 million achieved in the first nine months of the year. Thanks."]}, {"name": "nine month", "questions": ["You indicated that you took EUR78 million in exceptional costs in the first nine months for efficiency measures. I was wondering if you could quantify the amount of savings that EUR78 million achieved in the first nine months of the year. Thanks."]}, {"name": "efficiency measure", "questions": ["You indicated that you took EUR78 million in exceptional costs in the first nine months for efficiency measures. I was wondering if you could quantify the amount of savings that EUR78 million achieved in the first nine months of the year. Thanks."]}, {"name": "saving", "questions": ["You indicated that you took EUR78 million in exceptional costs in the first nine months for efficiency measures. I was wondering if you could quantify the amount of savings that EUR78 million achieved in the first nine months of the year. Thanks."]}, {"name": "amount", "questions": ["You indicated that you took EUR78 million in exceptional costs in the first nine months for efficiency measures. I was wondering if you could quantify the amount of savings that EUR78 million achieved in the first nine months of the year. Thanks."]}, {"name": "asset", "questions": ["Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "custody", "questions": ["Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "rest", "questions": ["Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "result", "questions": ["Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "transfer", "questions": ["Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "ubs", "questions": ["Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "clearstream", "questions": ["Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks.", "Hi, good afternoon. I know you indicated that assets under custody should continue to develop positively throughout the rest of the year as the result of the transfer of assets from UBS. I was just hoping you could quantify how much in assets you're expecting to be transferred into Clearstream? Thank you."]}, {"name": "recent mifid ii proposal", "questions": ["Hello. Good afternoon. I just was hoping you could comment on the recent MiFID II proposals, specifically with regards to non-discriminatory access to indices and the open access requirement, as well. Thank you."]}, {"name": "non-discriminatory access", "questions": ["Hello. Good afternoon. I just was hoping you could comment on the recent MiFID II proposals, specifically with regards to non-discriminatory access to indices and the open access requirement, as well. Thank you.", "Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks."]}, {"name": "index", "questions": ["Hello. Good afternoon. I just was hoping you could comment on the recent MiFID II proposals, specifically with regards to non-discriminatory access to indices and the open access requirement, as well. Thank you.", "Great, and what about indices, as well, please?", "Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks."]}, {"name": "access", "questions": ["Hello. Good afternoon. I just was hoping you could comment on the recent MiFID II proposals, specifically with regards to non-discriminatory access to indices and the open access requirement, as well. Thank you.", "Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks."]}, {"name": "rbc", "questions": ["Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks.", "Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on extraordinary returns to shareholders. I know you keep referencing that it will be possible at some point as it was in the past, but it hasn't occurred now in about three years. And I was curious. What needs to change from a leverage and a financial performance point of view for you to recommence extraordinary returns to shareholders? Thanks.", "Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on the MD&amp;S segment. Last year it seemed on a quarterly basis to average roughly in the mid-EUR90s million in net revenue per quarter, and now we're north of EUR110 million, and I do acknowledge that there is a small one-off in that number. But should this be the new run rate, going forward for that unit? Thanks.", "Hi, good afternoon, it's Peter Lenardos from RBC in London. I had a question about Xetra. I understand it's a small part of the business, but the revenue yield looks to have declined dramatically during the quarter. And I was hoping you could comment on why that's the case and if competition had any impact on that. Thank you.", "Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks.", "Good afternoon, gentlemen. It's Peter Lenardos from RBC in London. I just had one question. In your H2 or H1 report, you indicate that you've increased your litigation provisions. I was just curious. Why have you increased them, and what litigation does that relate to? Thank you.", "Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks."]}, {"name": "london", "questions": ["Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks.", "Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on extraordinary returns to shareholders. I know you keep referencing that it will be possible at some point as it was in the past, but it hasn't occurred now in about three years. And I was curious. What needs to change from a leverage and a financial performance point of view for you to recommence extraordinary returns to shareholders? Thanks.", "Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on the MD&amp;S segment. Last year it seemed on a quarterly basis to average roughly in the mid-EUR90s million in net revenue per quarter, and now we're north of EUR110 million, and I do acknowledge that there is a small one-off in that number. But should this be the new run rate, going forward for that unit? Thanks.", "Hi, good afternoon, it's Peter Lenardos from RBC in London. I had a question about Xetra. I understand it's a small part of the business, but the revenue yield looks to have declined dramatically during the quarter. And I was hoping you could comment on why that's the case and if competition had any impact on that. Thank you.", "Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks.", "Good afternoon, gentlemen. It's Peter Lenardos from RBC in London. I just had one question. In your H2 or H1 report, you indicate that you've increased your litigation provisions. I was just curious. Why have you increased them, and what litigation does that relate to? Thank you.", "Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks."]}, {"name": "update", "questions": ["Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks.", "Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks.", "Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks."]}, {"name": "mifid 2 proposal", "questions": ["Hi. Good afternoon. It's Peter Lenardos from RBC in London. I was just hoping to get an update on your recent thoughts with regard to the MiFID 2 proposals, specifically with regard to open access and non-discriminatory access to indices. Thanks."]}, {"name": "extraordinary return", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on extraordinary returns to shareholders. I know you keep referencing that it will be possible at some point as it was in the past, but it hasn't occurred now in about three years. And I was curious. What needs to change from a leverage and a financial performance point of view for you to recommence extraordinary returns to shareholders? Thanks."]}, {"name": "shareholder", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on extraordinary returns to shareholders. I know you keep referencing that it will be possible at some point as it was in the past, but it hasn't occurred now in about three years. And I was curious. What needs to change from a leverage and a financial performance point of view for you to recommence extraordinary returns to shareholders? Thanks."]}, {"name": "leverage", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on extraordinary returns to shareholders. I know you keep referencing that it will be possible at some point as it was in the past, but it hasn't occurred now in about three years. And I was curious. What needs to change from a leverage and a financial performance point of view for you to recommence extraordinary returns to shareholders? Thanks."]}, {"name": "view", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on extraordinary returns to shareholders. I know you keep referencing that it will be possible at some point as it was in the past, but it hasn't occurred now in about three years. And I was curious. What needs to change from a leverage and a financial performance point of view for you to recommence extraordinary returns to shareholders? Thanks."]}, {"name": "gross debt", "questions": ["I know that you commented on your gross debt to EBITDA levels. But I was wondering if you could comment also on the absolute balance of your net debt to EBIT -- your net debt as of yearend. Thanks."]}, {"name": "ebitda level", "questions": ["I know that you commented on your gross debt to EBITDA levels. But I was wondering if you could comment also on the absolute balance of your net debt to EBIT -- your net debt as of yearend. Thanks."]}, {"name": "ebit", "questions": ["I know that you commented on your gross debt to EBITDA levels. But I was wondering if you could comment also on the absolute balance of your net debt to EBIT -- your net debt as of yearend. Thanks."]}, {"name": "absolute balance", "questions": ["I know that you commented on your gross debt to EBITDA levels. But I was wondering if you could comment also on the absolute balance of your net debt to EBIT -- your net debt as of yearend. Thanks."]}, {"name": "net debt", "questions": ["I know that you commented on your gross debt to EBITDA levels. But I was wondering if you could comment also on the absolute balance of your net debt to EBIT -- your net debt as of yearend. Thanks."]}, {"name": "yearend", "questions": ["I know that you commented on your gross debt to EBITDA levels. But I was wondering if you could comment also on the absolute balance of your net debt to EBIT -- your net debt as of yearend. Thanks."]}, {"name": "md segment", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on the MD&amp;S segment. Last year it seemed on a quarterly basis to average roughly in the mid-EUR90s million in net revenue per quarter, and now we're north of EUR110 million, and I do acknowledge that there is a small one-off in that number. But should this be the new run rate, going forward for that unit? Thanks."]}, {"name": "quarterly basis", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on the MD&amp;S segment. Last year it seemed on a quarterly basis to average roughly in the mid-EUR90s million in net revenue per quarter, and now we're north of EUR110 million, and I do acknowledge that there is a small one-off in that number. But should this be the new run rate, going forward for that unit? Thanks."]}, {"name": "net revenue", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on the MD&amp;S segment. Last year it seemed on a quarterly basis to average roughly in the mid-EUR90s million in net revenue per quarter, and now we're north of EUR110 million, and I do acknowledge that there is a small one-off in that number. But should this be the new run rate, going forward for that unit? Thanks."]}, {"name": "unit", "questions": ["Hi, good afternoon. It's Peter Lenardos from RBC in London. A quick question on the MD&amp;S segment. Last year it seemed on a quarterly basis to average roughly in the mid-EUR90s million in net revenue per quarter, and now we're north of EUR110 million, and I do acknowledge that there is a small one-off in that number. But should this be the new run rate, going forward for that unit? Thanks."]}, {"name": "xetra", "questions": ["Hi, good afternoon, it's Peter Lenardos from RBC in London. I had a question about Xetra. I understand it's a small part of the business, but the revenue yield looks to have declined dramatically during the quarter. And I was hoping you could comment on why that's the case and if competition had any impact on that. Thank you."]}, {"name": "revenue yield", "questions": ["Hi, good afternoon, it's Peter Lenardos from RBC in London. I had a question about Xetra. I understand it's a small part of the business, but the revenue yield looks to have declined dramatically during the quarter. And I was hoping you could comment on why that's the case and if competition had any impact on that. Thank you."]}, {"name": "competition", "questions": ["Hi, good afternoon, it's Peter Lenardos from RBC in London. I had a question about Xetra. I understand it's a small part of the business, but the revenue yield looks to have declined dramatically during the quarter. And I was hoping you could comment on why that's the case and if competition had any impact on that. Thank you."]}, {"name": "criminal investigation", "questions": ["Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks.", "Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks."]}, {"name": "investigation", "questions": ["Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks.", "Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks."]}, {"name": "beginning", "questions": ["Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks."]}, {"name": "potential timeline", "questions": ["Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks."]}, {"name": "resolution", "questions": ["Hi. Good afternoon, Gregor. It's Peter from RBC in London. A question on the US criminal investigation. You mentioned the -- or the legal issues in the US at the beginning of your talk. But I guess we haven't had an update on that in quite a while, and I was just curious if there was any thoughts on how the investigation is progressing and what a potential timeline is for resolution. Thanks."]}, {"name": "h2", "questions": ["Good afternoon, gentlemen. It's Peter Lenardos from RBC in London. I just had one question. In your H2 or H1 report, you indicate that you've increased your litigation provisions. I was just curious. Why have you increased them, and what litigation does that relate to? Thank you."]}, {"name": "matter", "questions": ["Good afternoon, gentlemen, it's Peter Lenardos from RBC in London. I just had a question. Is there still a criminal investigation pending with regards to Clearstream in the US, and if there's been any update whatsoever on that matter? Thanks."]}]}
